glp-1 and mash The Interplay Between GLP-1-Based Therapies, the Gut Microbiome, MASLD/ in Type 2 Diabetes Mellitus: A Narrative Review GLP-1 BREAKTHROUGH: FDA APPROVES TREATMENT

The vast majority of people taking semaglutide do not develop allodynia

In fact, it stimulates more GLP-1 release than carbs or fat alone

[PubMed] [Google Scholar] 30

It invites readers to see medicine not merely as a science of intervention, but as a discipline of perception, empathy, and awarenessan approach essential for thoughtful practice in the 21st century

This is much of what I do now: working with people after GLP-1 use to put the missing half back in

Patients who do not consciously increase fluid intake to compensate for these physiological changes may experience symptoms of dehydration, including dry mouth, concentrated urine, and fatigue